Literature DB >> 15121969

Application of the resource-based relative value scale system to pediatrics.

.   

Abstract

In today's rapidly changing health care environment, it is crucial to understand the genesis and principles behind the Medicare Resource-Based Relative Value Scale (RBRVS) physician fee schedule. Many third-party payers, including state Medicaid programs, BlueCross BlueShield, and managed care organizations, use variations of the Medicare RBRVS to determine physician reimbursement and capitation rates. Because the RBRVS fee schedule was created originally for Medicare only, pediatric-specific Current Procedural Terminology (CPT) codes and pediatric practice expense calculations were not included. The American Academy of Pediatrics supports the use of CPT codes and the RBRVS physician fee schedule and continues to work to rectify certain inequities of the RBRVS system as they pertain to pediatrics.

Mesh:

Year:  2004        PMID: 15121969     DOI: 10.1542/peds.113.5.1437

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  The role of remuneration in clinical productivity of paediatric physicians.

Authors:  Sanober S Motiwala; Peter C Coyte
Journal:  Paediatr Child Health       Date:  2010-03       Impact factor: 2.253

2.  Pilot study comparing patients' valuation of health-care services with Medicare's relative value units.

Authors:  Steven J Kravet; Heather Jones; Eric E Howell; Scott M Wright
Journal:  Health Expect       Date:  2008-12       Impact factor: 3.377

Review 3.  Integrating Children's Mental Health into Primary Care.

Authors:  Lawrence S Wissow; Nadja van Ginneken; Jaya Chandna; Atif Rahman
Journal:  Pediatr Clin North Am       Date:  2016-02       Impact factor: 3.278

4.  Physician ownership of ambulatory surgery centers and practice patterns for urological surgery: evidence from the state of Florida.

Authors:  Seth A Strope; Stephanie Daignault; John M Hollingsworth; Zaojun Ye; John T Wei; Brent K Hollenbeck
Journal:  Med Care       Date:  2009-04       Impact factor: 2.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.